A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in Glioblastoma

Sied Kebir(University of Bonn), Björn Scheffler(German Cancer Research Center), Guido Reifenberger(Düsseldorf University Hospital), Verena Jendrossek(German Cancer Research Center), Franziska K. Lorbeer(Whitehead Institute for Biomedical Research), Michael Weller(University Hospital of Zurich), Frank K.H. van Landeghem(University of Alberta), Christel Herold‐Mende, Barbara M. Grüner(Düsseldorf University Hospital), Oliver Brüstle(University of Bonn), Alexander Roesch(Essen University Hospital), Tobias Blau(University of Duisburg-Essen), Matthias Simon(University of Bonn), Timo Wilhelm-Buchstab(University Hospital Bonn), Igor Cima(Deutsches Konsortium für Translationale Krebsforschung), Anja Wieland(University of Bonn), Johann Matschke(Essen University Hospital), Marc Remke(Saarland University), Pia Berger(German Cancer Research Center), Daniel Trageser(University of Bonn), Kathy Keyvani(Essen University Hospital), Torsten Pietsch(University Hospital Bonn), Ulrich Sure(University of Duisburg-Essen), Holger Fröhlich(Fraunhofer Institute for Algorithms and Scientific Computing), Jörg Felsberg(Heinrich Heine University Düsseldorf), Jens T. Siveke(German Cancer Research Center), Vivien Ullrich(German Cancer Research Center), Laurèl Rauschenbach(University of Bonn), Andreas Till(University of Bonn), Shruthi Prasad(German Cancer Research Center), Sarah Langer(German Cancer Research Center), Martin Glas(Essen University Hospital), Celia Dobersalske(Düsseldorf University Hospital), Ashar Ahmad(University of Bonn)
Clinical Cancer Research
October 14, 2022
Cited by 4


Related Papers